Stock Details

Enter Company or Symbol. Press down arrow for suggestions, or Escape to return to entry field.

RELATED RESOURCES

Print Format

Change Text Size:

BRIEF-Ocugen Says U.S. Patent And Trademark Office Issued Patent To Co

BY Reuters
— 4:16 PM ET 08/31/2020

Aug 31 (Reuters) - Ocugen Inc (OCGN):

* OCUGEN INC (OCGN) - ON AUGUST 25, U.S. PATENT AND TRADEMARK OFFICE ISSUED PATENT TO CO

* OCUGEN INC (OCGN) - PATENT RELATES TO OCU300 AND OCU310, TWO PRODUCT CANDIDATES THAT COMPANY HAD PREVIOUSLY BEEN DEVELOPING

* OCUGEN INC (OCGN) - NOT CURRENTLY DEVELOPING ANY THERAPIES RELATED TO PATENT Source : (https://bit.ly/34NNZ9R) Further company coverage:

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

More OCGN News

Ocugen to Present at the LD 500 Virtual Investor Conference
GlobeNewswire - 7:40 AM ET 08/28/2020
Ocugen Provides Business Update and Second Quarter 2020 Financial Results
GlobeNewswire - 7:30 AM ET 08/14/2020
Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases
GlobeNewswire - 7:30 AM ET 08/10/2020